The trajectory of Viagra presents a challenging picture for shareholders. While the initial launch generated substantial returns, the end of its patent opened the floodgates to off-brand versions, dramatically eroding https://montyrktn258869.blogripley.com/42616356/sildenafil-and-pharma-a-precarious-opportunity